Willoughby John J, Jensen Abbie M
Biology Department, University of Massachusetts, Amherst, MA 01003, USA.
Dis Model Mech. 2025 Jan 1;18(1). doi: 10.1242/dmm.052052. Epub 2025 Jan 10.
Stargardt disease (STGD), the leading cause of inherited childhood blindness, is primarily caused by mutations in the ABCA4 gene; yet, the underlying mechanisms of photoreceptor degeneration remain elusive, partly due to limitations in existing animal disease models. To expand our understanding, we mutated the human ABCA4 paralogues abca4a and abca4b in zebrafish, which has a cone-rich retina. Our study unveiled striking dysmorphology and elongation of cone outer segments (COS) in abca4a;abca4b double mutants, alongside reduced phagocytosis by the retinal pigmented epithelium (RPE). We report that zebrafish Abca4 protein forms a distinctive stripe along the length of COS, suggesting a potential structural role. We further show that, in wild-type zebrafish, outer segments of cone cells constitutively present externalized phosphatidylserine, an apoptotic 'eat-me' signal, and that this pattern is disrupted in abca4a;abca4b double mutants, potentially contributing to reduced RPE phagocytic activity. More broadly, constitutive presentation of the 'eat-me' signal by COS - if conserved in humans - might have important implications for other retinal degenerative diseases, including age-related macular degeneration. Our zebrafish model provides novel insights into cone dysfunction and presents a promising platform for unraveling the mechanisms of STGD pathogenesis and advancing therapeutic interventions.
斯塔加特病(STGD)是遗传性儿童失明的主要原因,主要由ABCA4基因突变引起;然而,光感受器退化的潜在机制仍然难以捉摸,部分原因是现有动物疾病模型存在局限性。为了拓展我们的认识,我们在具有富含视锥细胞视网膜的斑马鱼中使人类ABCA4旁系同源基因abca4a和abca4b发生突变。我们的研究揭示了abca4a;abca4b双突变体中视锥细胞外节(COS)出现显著的形态异常和伸长,同时视网膜色素上皮(RPE)的吞噬作用降低。我们报告斑马鱼Abca4蛋白沿COS长度形成一条独特的条纹,表明其具有潜在的结构作用。我们进一步表明,在野生型斑马鱼中,视锥细胞的外节组成性地呈现外化的磷脂酰丝氨酸,这是一种凋亡的“吃我”信号,而这种模式在abca4a;abca4b双突变体中被破坏,这可能导致RPE吞噬活性降低。更广泛地说,如果COS的“吃我”信号在人类中保守,可能对其他视网膜退行性疾病,包括年龄相关性黄斑变性具有重要意义。我们的斑马鱼模型为视锥细胞功能障碍提供了新的见解,并为阐明STGD发病机制和推进治疗干预提供了一个有前景的平台。